Clinical Trials Browser

Withdrawn × Trabectedin × Sarcoma × Clear all

NCT03397186 2019-09-10

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Phase 2 Withdrawn

Sarcoma, Liposarcoma, Myxoid

NCT03496519 2018-10-09

Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors

Phase 1 Withdrawn

SarcomaThoracic

Lung Neoplasms, Sarcoma